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Letter to the Editor 
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Synoptic reporting (SR) increases completeness and improves the understanding of pathology 
reports for tumours as compared to the more traditional “narrative” style. Furthermore, it is an 
important step towards higher levels of structured data capture[4]. SR is defined by a set of required 
data elements (RDE) specific for each tumour type and a characteristic paired format of RDE and 
response. The College of American Pathologists (CAP) requires accredited pathology laboratories to 
report many cancer types in a synoptic format and for this purpose publishes a comprehensive set of 
protocols[1]. More recently, the International Collaboration for Cancer Reporting (ICCR) – sponsored 
amongst others by the European Society of Pathology – has started to publish synoptic protocols 
with the aim to “produce internationally standardised and evidence-based datasets for the pathology 
reporting of cancer”[2]. 
One arguably underestimated challenge with regard to widespread implementation of SR is that – 
with the noteworthy exception of Dutch protocols published by the PALGA foundation[3] – protocols 
are exclusively available in English. This does not only result in barriers to introduce SR for pathology 
departments that report in other languages, but also jeopardizes one of the main benefits of SR, i.e. 
uniformity of terminology between institutions, across country and language barriers. The Institute 
of Pathology at the University of Bern recently launched an initiative for SR of all major cancer types. 
Given that the Canton of Bern is bilingual (German and French) and that we report in both languages, 
we sought to define an approach for translating existing protocols to German as well as French, 
ensuring precision, clarity and consistency between protocols.  Because of the currently much more 
comprehensive set of protocols, we opted to use CAP (rather than ICCR) protocols, which are freely 
available (with certain restrictions regarding integration into pathology information systems). 
Importantly, we identified recurrent terms and ensured that these were translated consistently 
between the different protocols (Table 1). We sought to adhere as close as possible to the original 
English terminology, but found literal translation impracticable for some terms.  We made a 
particular effort to ensure patient safety by avoiding terms prone to misinterpretation. For this 
purpose, for example, we translated “well differentiated” to German “gut differenziert” rather than 
the widely used alternative “hoch differenziert” – literally translated: “highly differentiated”. This 
was done to avoid confusion with “hochgradig” (“high grade”). We also made sure that positive and 
negative responses would not differ by only a single word, the accidental omission of which would 
invert the meaning. For instance, we translated “not identified” to German “nicht nachgewiesen” 
rather than the more customary term “nicht vorhanden” for a negative finding, which would differ 
from “vorhanden” (“present”) only by the negation “nicht”. Sample reports for the lung carcinoma 
protocol to highlight these points are provided as supplementary data. 
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Based on our experience with two years of SR, 20 surgical and biomarker protocols adopted so far, 
and more than 1000 synoptic reports issued, we conclude that widespread implementation of SR in 
languages other than English is feasible, but neither a trivial nor an effortless endeavour.  
All five Swiss academic pathology institutes collaborate to date on PathoLink, a common bilingual 
(German and French) structured reporting system to enhance data interoperability for cancer 
registration and data exchange in the frame of personalized health. 
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English German French 
Recurrent Terms 
Procedure Art der Resektion Type de pièce opératoire 
Tumor Site Tumorlokalisation Localisation de la tumeur 
Histological type Histologischer Typ Type histologique 
Histological Grade Histologischer Grad Grade histologique 
Tumor Size, Greatest 
Dimension 
Maximaler Tumordurchmesser Taille de la tumeur, Plus 
grande dimension 
Margin Resektionsrand Berge d’exérèse 
Treatment Effect Therapie-Effekt Réponse au traitement 
Regional Lymph Nodes Regionäre Lymphknoten Ganglions lymphatiques 
régionaux 
Tumor extension Tumorausdehnung Extension tumorale 
(Lymph Nodes etc.) submitted Eingesandte (Lymphknoten 
etc.) 
(Ganglions etc.) soumis 
(Lymph Nodes etc.) examined Untersuchte (Lymphknoten 
etc.) 
(Ganglions etc.) examinés 
(Lymph Nodes etc.) involved Befallen (Lymphknoten etc.) (Ganglions etc.) envahis 
Additional Pathologic Findings Zusätzliche pathologische 
Befunde 
Autres lésions 
histopathologiques 
Mitotic rate Mitoserate Index mitotique 
Ki-67 labeling index Prolifererationsrate (Ki-67) Index de proliferation (Ki-67) 
Perineural invasion Perineuralscheideninfiltration Infiltration périnerveuse 
Not applicable Nicht zutreffend Non applicable 
Cannot be assessed Kann nicht beurteilt werden Ne peut être évalué 
Cannot be determined Kann nicht bestimmt werden Impossible à déterminer 
Recurrent Terms – Special considerations 
Tumor focality Anzahl Tumorherde 
Literally: "Number of Tumor 
Foci" 
Nombre de foyers tumoraux 
Literally: "Number of Tumor 
Foci"  
Extranodal Extension Extrakapsuläre Ausbreitung 
Widely used term 
Effraction capsulaire 
Brisk / Non-brisk 
Semiquantitative assessment 
of Tumour-infiltrating 
lymophocytes in melanoma 
Reichlich vorhanden ("brisk") / 
spärlich vorhanden ("non-
brisk") 
Established English terms in 
parentheses  
Intense (“brisk”) / modéré 
(“non-brisk”) 
Uninvolved Tumorfrei  
Literally: "Free of Tumor" 
Sain 
Literally: "Healthy” 
Well differentiated Gut differenziert 
Rather than “hoch 
differenziert” to avoid 
confusion with “high grade” 
Bien différencié 
Moderately differentiated Mässig differenziert Moyennement différencié 
Poorly differentiated Wenig differenziert Peu différencié 
Present Vorhanden Présent 
Not identified Nicht nachgewiesen 
Rather than “nicht vorhanden” 
in order not to differ from 
"vorhanden” only by one word 
Non identifié 
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Table 1: Examples of German and French translations for recurrent terms in the CAP protocols. 
Comments in italics. 
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